Cargando…

The comparative effects of intravenous iron on oxidative stress and inflammation in patients with chronic kidney disease and iron deficiency: a randomized controlled pilot study

BACKGROUND: Concerns exist regarding the pro-oxidant and inflammatory potential of intravenous (IV) iron due to labile plasma iron (LPI) generation. This IRON-CKD trial compared the effects of different IV irons on oxidative stress and inflammation. METHODS: In this randomized open-label explorative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kassianides, Xenophon, Gordon, Andrew, Sturmey, Roger, Bhandari, Sunil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Nephrology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041632/ https://www.ncbi.nlm.nih.gov/pubmed/33745264 http://dx.doi.org/10.23876/j.krcp.20.120

Ejemplares similares

Analysis of oxidative stress, inflammation and endothelial function following intravenous iron in chronic kidney disease in the Iron and Heart Trial
por: Kassianides, Xenophon, et al.
Publicado: (2022)

Correction to: Protocol and baseline data for a prospective open-label explorative randomized singlecenter comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD)
por: Ziedan, Ahmed, et al.
Publicado: (2020)

Markers of Oxidative Stress, Inflammation and Endothelial Function following High-Dose Intravenous Iron in Patients with Non-Dialysis-Dependent Chronic Kidney Disease—A Pooled Analysis
por: Kassianides, Xenophon, et al.
Publicado: (2022)

Patient reported outcome measures and cardiovascular outcomes following high dose modern intravenous iron in non-dialysis dependent chronic kidney disease: secondary analysis of ExplorIRON-CKD
por: Kassianides, Xenophon, et al.
Publicado: (2023)

The Impact of Intravenous Iron on Renal Injury and Function Markers in Patients With Chronic Kidney Disease and Iron Deficiency Without Anemia
por: Kassianides, Xenophon, et al.
Publicado: (2021)

Hypophosphataemia, fibroblast growth factor 23 and third-generation intravenous iron compounds: a narrative review
por: Kassianides, Xenophon, et al.
Publicado: (2021)

Impact of Intravenous Iron on Oxidative Stress and Mitochondrial Function in Experimental Chronic Kidney Disease
por: Nuhu, Faisal, et al.
Publicado: (2019)

Point-of-care testing technologies for the home in chronic kidney disease: a narrative review
por: Bodington, Richard, et al.
Publicado: (2021)

Safety of intravenous iron use in chronic kidney disease
por: Kalra, Philip A., et al.
Publicado: (2016)

Protocol and baseline data for a prospective open-label explorative randomized single-center comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD)
por: Ziedan, Ahmed, et al.
Publicado: (2019)

Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy
por: Wesström, Jan
Publicado: (2020)

Measurement of Glutathione as a Tool for Oxidative Stress Studies by High Performance Liquid Chromatography
por: Nuhu, Faisal, et al.
Publicado: (2020)

Intravenous Iron Therapy with Saccharated Iron Oxide
por: Deshmukh, P. L.
Publicado: (1952)

Efficacy and safety of iron isomaltoside (Monofer(®)) in the management of patients with iron deficiency anemia
por: Kalra, Philip A, et al.
Publicado: (2016)

Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
por: Froessler, Bernd, et al.
Publicado: (2018)

Comparative analysis of oral and intravenous iron therapy in rat models of inflammatory anemia and iron deficiency
por: de Souza, Lara Valente, et al.
Publicado: (2022)

Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice
por: Bhandari, Sunil
Publicado: (2011)

Intravenous Irons: From Basic Science to Clinical Practice
por: Bhandari, Sunil, et al.
Publicado: (2018)

Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations
por: Koch, Todd A., et al.
Publicado: (2015)

Incidence of Iron Deficiency and the Role of Intravenous Iron Use in Perioperative Periods
por: Țigliș, Mirela, et al.
Publicado: (2020)

A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients
por: Qunibi, Wajeh Y., et al.
Publicado: (2011)

Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study
por: Mafodda, Antonino, et al.
Publicado: (2017)

Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2013)

Comparative Evaluation of Sucrosomial Iron and Iron Oxide Nanoparticles as Oral Supplements in Iron Deficiency Anemia in Piglets
por: Mazgaj, Rafał, et al.
Publicado: (2021)

A Randomized Trial of Intravenous Iron Supplementation and Exercise on Exercise Capacity in Iron-Deficient Nonanemic Patients With CKD
por: Greenwood, Sharlene A., et al.
Publicado: (2023)

A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status
por: Bhandari, S., et al.
Publicado: (2021)

Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2011)

Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?
por: McDonagh, Theresa, et al.
Publicado: (2015)

Commentary: Iron deficiency of pregnancy - a new approach involving intravenous iron
por: Auerbach, Michael
Publicado: (2018)

Oral versus intravenous iron therapy in iron deficiency anemia: An observational study
por: Das, Samarendra N., et al.
Publicado: (2020)

Platelet reactivity and platelet count in women with iron deficiency treated with intravenous iron
por: Elstrott, Benjamin K., et al.
Publicado: (2022)

Prevalence of Iron Deficiency Anemia Indicated for Intravenous Iron Treatment in the Korean Population
por: Choi, Rihwa, et al.
Publicado: (2023)

Intravenous Iron Technique Evaluation in Chronic Heart Failure With Iron Deficiency Anemia
por: Gosavi, Rohit, et al.
Publicado: (2023)

FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
por: Macdougall, Iain C., et al.
Publicado: (2014)

Intravenous iron isomaltoside versus oral iron supplementation for treatment of iron deficiency in pregnancy: protocol for a randomised, comparative, open-label trial
por: Markova, Veronika, et al.
Publicado: (2020)

Intravenous ferric carboxymaltose for the management of iron deficiency and iron deficiency anaemia in children and adolescents: a review
por: Aksan, Aysegül, et al.
Publicado: (2022)

Markers of oxidative/nitrosative stress and inflammation in lung tissue of rats exposed to different intravenous iron compounds
por: Toblli, Jorge E, et al.
Publicado: (2017)

Effect of Intravenous Iron Supplementation on Iron Stores in Non-Anemic Iron-Deficient Patients with Hereditary Hemorrhagic Telangiectasia
por: Karlsson, Torbjörn, et al.
Publicado: (2016)

Pharmacokinetics of ferric bepectate—a new intravenous iron drug for treating iron deficiency
por: Muñoz, Manuel, et al.
Publicado: (2019)

Improving the Outcome of Patients With Heart Failure: Assessment of Iron Deficiency and Intravenous Iron Replacement
por: Yera, Hassan O, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3ddpd3ngftd8orijai9nia8ar5